Melissa Tuck
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Monoclonal and Polyclonal Antibodies Research, Cancer Genomics and Diagnostics, Radiopharmaceutical Chemistry and Applications, Advanced Proteomics Techniques and Applications
Most-Cited Works
- → Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group(2008)718 cited
- → 131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma(2005)715 cited
- → Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the University of Michigan experience(2000)521 cited
- → Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.(1996)401 cited
- → Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC)(2020)32 cited
- → Tositumomab and Iodine I-131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma: Median 10 Year Follow-up Results.(2009)25 cited
- → ctDNA transiting into urine is ultrashort and facilitates noninvasive liquid biopsy of HPV+ oropharyngeal cancer(2024)20 cited
- → Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1(2022)18 cited
- → I131-tositumomab monotherapy as frontline treatment for follicular lymphoma: Updated results after a median follow-up of 8 years(2007)14 cited